| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1056/NEJM199201233260406 |
| P698 | PubMed publication ID | 1727977 |
| P50 | author | Lina Badimon | Q38545654 |
| Valentín Fuster Carulla | Q977751 | ||
| P2093 | author name string | Badimon JJ | |
| Chesebro JH | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | acute coronary syndrome | Q266018 |
| pathogenesis | Q372016 | ||
| coronary artery disease | Q844935 | ||
| P304 | page(s) | 242-250 | |
| P577 | publication date | 1992-01-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | The pathogenesis of coronary artery disease and the acute coronary syndromes (1). | |
| P478 | volume | 326 |
| Q35968518 | "Vulnerable plaques"--ticking of the time bomb |
| Q39878866 | (18)F-fluorodeoxyglucose PET imaging of coronary atherosclerosis and plaque inflammation |
| Q27348866 | A Novel Model of Intravital Platelet Imaging Using CD41-ZsGreen1 Transgenic Rats |
| Q42928754 | A case of acute myocardial infarction caused by distal embolization of a left main coronary artery thrombus |
| Q34800954 | A few immobilized thrombins are sufficient for platelet spreading |
| Q37336145 | A novel variant in the platelet endothelial aggregation receptor-1 gene is associated with increased platelet aggregability |
| Q37639809 | A pathological study of the epidemiology of atherosclerosis in Mexico city |
| Q84040637 | A polymorphism in the visfatin gene promoter is related to decreased plasma levels of inflammatory markers in patients with coronary artery disease |
| Q34733008 | A reliable plasma marker of platelet activation: does it exist? |
| Q38363238 | ABCA1-mediated cholesterol efflux is defective in free cholesterol-loaded macrophages. Mechanism involves enhanced ABCA1 degradation in a process requiring full NPC1 activity |
| Q35621207 | Abnormalities associated with progressive aortic vascular dysfunction in chronic kidney disease. |
| Q42233317 | Accelerated atheromatous lesions in mouse hearts transplanted to apolipoprotein-E-deficient recipients |
| Q40494782 | Accelerated hypertension and nephroangiosclerosis associated with antiphospholipid syndrome. Report of two cases and review of the literature |
| Q40854366 | Activated and total coagulation factor VII, and fibrinogen in coronary artery disease |
| Q73364939 | Acute Coronary Syndromes: Molecular Basis for Cardiac Risk Factors |
| Q52537418 | Acute Myocardial Infarction and the Role of Aspirin, Heparin, and Warfarin. |
| Q33968801 | Acute ST-segment elevation myocardial infarction in a young patient with essential thrombocythemia: a case with long-term follow-up report |
| Q33827278 | Acute coronary syndromes: pathology, diagnosis, genetics, prevention, and treatment |
| Q41266711 | Acute renal infarction resulting from fibromuscular dysplasia: a case report |
| Q43266392 | Adding clopidogrel to aspirin improves outcome in ST-elevation myocardial infarction patients receiving fibrinolytic therapy |
| Q73365812 | Adjunctive Antiplatelet Therapy in Acute Myocardial Infarction: The Road to Improved Infarct-Related Artery Patency |
| Q34748832 | Administration of glycoprotein IIb-IIIa inhibitors in patients with ST-segment elevation myocardial infarction |
| Q37766138 | Advances in gene-based therapy for heart failure |
| Q28199568 | Aggressive antiplatelet therapy before coronary stent implantation in acute coronary syndrome with essential thrombocythemia--a case report |
| Q34308216 | Alternatively spliced tissue factor promotes plaque angiogenesis through the activation of hypoxia-inducible factor-1α and vascular endothelial growth factor signaling |
| Q30372587 | An Endovascular Cannulation Needle with an Internal Wire for the Fragmentation of Thrombi in Retinal Vein Occlusion |
| Q37359345 | Anatomic characteristics of culprit sites in acute coronary syndromes |
| Q73681249 | Angiographic Morphology Following Heparin and Aspirin Therapy in Patients with Acute Coronary Syndromes and Intracoronary Thrombus |
| Q50918376 | Anti-atherogenicity in women does not prevent restenosis after balloon angioplasty. |
| Q36979647 | Anti-inflammatory action of diltiazem in patients with unstable angina |
| Q37221177 | Anti-inflammatory effect of abciximab-coated stent in a porcine coronary restenosis model |
| Q33588514 | Antibiotics for myocardial infarction? A possible role of infection in atherogenesis and acute coronary syndromes |
| Q26824864 | Anticoagulants for secondary prevention after acute myocardial infarction: lessons from the past decade |
| Q34441606 | Anticoagulation and the heart |
| Q46433881 | Antiplatelet activities of newly synthesized derivatives of piperlongumine. |
| Q37437158 | Antiplatelet drug 'resistance'. Part 1: mechanisms and clinical measurements |
| Q34111901 | Antiplatelet medications and their indications in preventing and treating coronary thrombosis |
| Q53476976 | Antiplatelet therapy and platelet function testing. Introduction. |
| Q28167737 | Antiplatelet therapy in cardiovascular disease |
| Q33732646 | Antiplatelet therapy in the prevention of ischemic vascular events: literature review and evidence-based guidelines for drug selection. |
| Q43416129 | Antithrombotic effects of losartan in patients with hypertension complicated by atrial fibrillation: 4A (Angiotensin II Antagonist of platelet Aggregation in patients with Atrial fibrillation), a pilot study |
| Q37608567 | Antithrombotic strategies in non-ST elevation acute coronary syndromes: focus on bivalirudin |
| Q38715643 | Antithrombotic therapy in peripheral artery disease |
| Q34027525 | Antithrombotic therapy in the cardiac catheterization laboratory: focus on antiplatelet agents |
| Q41341898 | Antithrombotic treatment in stable coronary syndromes: long-term intermittent urokinase therapy in end-stage coronary artery disease and refractory angina pectoris |
| Q37919946 | Aortic atheromas: current knowledge and controversies: a brief review of the literature |
| Q44895988 | Apoptosis and plaque destabilization in atherosclerosis: the role of macrophage apoptosis induced by cholesterol |
| Q37880719 | Arteriosclerosis as a sequela of chronic Chlamydia pneumoniae infection |
| Q30535396 | Assessing atherosclerotic plaque morphology: comparison of optical coherence tomography and high frequency intravascular ultrasound |
| Q35986383 | Association between blood glucose variability and coronary plaque instability in patients with acute coronary syndromes |
| Q43853078 | Association between endothelial nitric oxide synthase gene polymorphism (-786T>C) and interleukin-6 in acute coronary syndrome |
| Q35225067 | Association between metabolic syndrome, smoking status and coronary artery calcification |
| Q51551601 | Association between periodontal disease and acute myocardial infarction. |
| Q33747958 | Association of Platelet Membrane Glycoprotein HPA-2a/b, GP VI T13254C, and GP Ibα VNTR Polymorphisms with Risk of Coronary Artery Disease: A Meta-Analysis. |
| Q36058977 | Association of matrix Gla protein gene allelic polymorphisms (G(-7)→A, T(-138)→C and Thr(83)→Ala) with acute coronary syndrome in the Ukrainian population. |
| Q54303525 | Association of thrombomodulin gene polymorphisms and plasma thrombomodulin levels with acute myocardial infarction in north Indian patients. |
| Q58492104 | Atherogenesis and Inflammation |
| Q55407911 | Atherosclerosis T1-weighted characterization (CATCH): evaluation of the accuracy for identifying intraplaque hemorrhage with histological validation in carotid and coronary artery specimens. |
| Q37882083 | Atherosclerosis due to chronic arteritis caused by Chlamydia pneumoniae: a tentative hypothesis |
| Q36390068 | Atherosclerosis imaging on the molecular level |
| Q26822655 | Atherosclerosis: process, indicators, risk factors and new hopes |
| Q46847348 | Atherosclerotic plaque imaging using phase-contrast X-ray computed tomography. |
| Q34122524 | Beneficial effects of statins in coronary artery disease--beyond lowering cholesterol |
| Q41036925 | Benefits and risks of HMG-CoA reductase inhibitors in the prevention of coronary heart disease: a reappraisal |
| Q40563626 | Bioequivalence and tolerability study of two brands of clopidogrel tablets, using inhibition of platelet aggregation and pharmacodynamic measures |
| Q35091945 | Blood coagulation in patients with chronic heart failure: evidence for hypercoagulable state and potential for pharmacological intervention |
| Q34032614 | C-reactive Protein as a Predictor of Adverse outcome in Patients with Acute Coronary Syndrome |
| Q31113902 | C-reactive protein as a marker for active coronary artery disease in patients with chest pain in the emergency room. |
| Q35793488 | CD40 ligation induces tissue factor expression in human vascular smooth muscle cells |
| Q80478882 | Calcium channel blockers increase the amount of nitrite production in rabbits without decreasing the responsiveness of platelets to collagen |
| Q40874805 | Calcium-channel antagonists for prevention of atherosclerosis |
| Q34557702 | Candidate genes as potential links between periodontal and cardiovascular diseases |
| Q41588632 | Candidate genes, small effects, and the prediction of atherosclerosis |
| Q34010261 | Cardiac magnetic resonance and computed tomography angiography for clinical imaging of stable coronary artery disease. Diagnostic classification and risk stratification |
| Q36488248 | Cardiac stem cell therapy: present and future |
| Q42763375 | Cardiovascular molecular imaging as a tool to study biology |
| Q51287938 | Carotid arterial intraplaque hemorrhage and calcification influences cerebral hemodynamics. |
| Q54663237 | Characteristics of periodontal microflora in acute myocardial infarction. |
| Q33935019 | Chlamydia pneumoniae and atherosclerotic risk in populations: the role of seroepidemiology |
| Q35633523 | Cholesterol and lipoproteins: beyond atherogenesis |
| Q33538129 | Cholesterol lowering and coronary artery disease: mechanisms of risk reduction. |
| Q33606548 | Circulating inflammatory and hemostatic biomarkers are associated with risk of myocardial infarction and coronary death, but not angina pectoris, in older men. |
| Q80106797 | Circulating platelet and neutrophil activation correlates with the clinical course of unstable angina |
| Q83603579 | Circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are associated with angiographic coronary lesion complexity in patients with coronary artery disease |
| Q43496940 | Clinical characteristics and intravascular ultrasound findings of culprit lesions in elderly patients with acute coronary syndrome |
| Q35021861 | Clinical features and prognosis of patients with coronary spasm-induced non-ST-segment elevation acute coronary syndrome |
| Q35609014 | Clinical use of aspirin in treatment and prevention of cardiovascular disease |
| Q28177271 | Clinical use of new antithrombotic therapies for medical management of acute coronary syndromes |
| Q89802649 | Clinical worsening despite intravenous thrombolysis in acute ischemic stroke secondary to carotid plaque rupture |
| Q41341044 | Clinically stable angina pectoris is not necessarily associated with histologically stable atherosclerotic plaques |
| Q40999488 | Clotting for the Clinician: An Overview of Thrombosis and Antithrombotic Therapy |
| Q40930567 | Commentary on myocardial stunning and its clinical relevance |
| Q38677500 | Comparative Effectiveness of Oral Antiplatelet Agents in Patients with Acute Coronary Syndrome |
| Q40054806 | Comparison of 3 Predictive Clinical Risk Scores in 603 Patients with Stable Coronary Artery Disease |
| Q40208690 | Comparison of Time Trends of Cardiovascular Disease Risk Factors and Framingham Risk Score Between Patients With and Without Acute Coronary Syndrome Undergoing Percutaneous Intervention Over the Last 17 Years: From the Mayo Clinic Percutaneous Coron |
| Q30406330 | Comparison of carotid plaque tissue characteristics in patients with acute coronary syndrome or stable angina pectoris: assessment by iPlaque, transcutaneous carotid ultrasonography with integrated backscatter analysis. |
| Q37708645 | Comparison of four methods of analysis of lipoprotein particle subfractions for their association with angiographic progression of coronary artery disease |
| Q36294835 | Comparison of iodinated contrast media for the assessment of atherosclerotic plaque attenuation values by CT coronary angiography: observations in an ex vivo model |
| Q55228800 | Comparison of the Brachial-ankle Pulse Wave Velocity between Patients with Acute Coronary Syndrome and Effort Angina Pectoris. |
| Q42867694 | Comparison of the Effects of Enoxaparin and Heparin on Inflammatory Biomarkers in Patients with ST-segment Elevated Myocardial Infarction: A prospective Open Label Pilot Clinical Trial |
| Q36870031 | Compartmentation and compartment-specific regulation of PDE5 by protein kinase G allows selective cGMP-mediated regulation of platelet functions |
| Q35433689 | Composition and classification of human atherosclerotic lesions |
| Q38437358 | Computational fluid dynamics in cardiovascular disease |
| Q51626877 | Computer simulations of atherosclerotic plaque growth in coronary arteries. |
| Q35019922 | Consolidated and emerging inflammatory markers in coronary artery disease |
| Q40685899 | Coronary arterial calcification as an active process: a new perspective on an old problem |
| Q73809234 | Coronary arterial remodeling in differing clinical presentations of unstable angina pectoris--an intravascular ultrasound study |
| Q34052597 | Coronary artery disease and human immunodeficiency virus infection |
| Q33655853 | Coronary atherosclerosis and interventions: pathological sequences and restenosis |
| Q41860989 | Coronary atherosclerosis in transplanted mouse hearts. I. Time course and immunogenetic and immunopathological considerations. |
| Q26866204 | Coronary atherosclerosis is already ongoing in pre-diabetic status: Insight from intravascular imaging modalities |
| Q33815095 | Coronary endothelial function in patients with obstructive sleep apnea |
| Q33802871 | Coronary microembolization--its role in acute coronary syndromes and interventions |
| Q41698436 | Correlation between interleukin 6 and interleukin 10 in acute myocardial infarction |
| Q40047995 | Correlation of antecedent stress myocardial perfusion imaging with the infarct related artery in ST-elevation myocardial infarction |
| Q73295874 | Coumadin Aspirin Reinfarction Study: Rationale and Design of the CARS Study |
| Q88196076 | Current Antithrombotic Therapy in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Interventions |
| Q28168871 | Current concepts in the antithrombotic management of non-ST-elevation acute coronary syndromes |
| Q36264216 | Current perspectives on laboratory markers for the assessment of cardiovascular disease and myocardial damage |
| Q40109843 | Current treatment and future prospects for the management of acute coronary syndromes: consensus recommendations of the 1997 ushuaia conference, tierra del fuego, Argentina |
| Q90467282 | Deceived incidence of acute coronary syndrome by measurement of FFR: Diagnostic gap of vulnerable plaque between physiology and morphology |
| Q33503491 | Dental plaque, platelets, and cardiovascular diseases |
| Q46770291 | Different effect of statins on platelet oxidized-LDL receptor (CD36 and LOX-1) expression in hypercholesterolemic subjects. |
| Q37639007 | Differential inhibitory action of apixaban on platelet and fibrin components of forming thrombi: Studies with circulating blood and in a platelet-based model of thrombin generation |
| Q45897317 | Dipeptidyl peptidases in atherosclerosis: expression and role in macrophage differentiation, activation and apoptosis. |
| Q37377651 | Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions |
| Q41609653 | Distinct structural attributes regulating von Willebrand factor A1 domain interaction with platelet glycoprotein Ibalpha under flow |
| Q50700582 | Distinguishing characteristics of erythrocyte-rich and platelet-rich thrombus by intravascular ultrasound catheter system. |
| Q36587023 | Do carotid surface irregularities correlate with the development of cerebrovascular symptoms? An analysis of the supporting studies, the opposing studies, and the possible pathomechanism |
| Q54187934 | Does lowering of cholesterol levels influence functional properties of large arteries? |
| Q38578543 | Dosing of rivaroxaban by indication: getting the right dose for the patient. |
| Q37367211 | Downregulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27(KIP1), an inhibitor of neointima formation in the rat carotid artery |
| Q73295912 | Dynamics of Vascular Remodeling: An Overview and Bibliography |
| Q35865366 | Dysferlin-mediated membrane repair protects the heart from stress-induced left ventricular injury |
| Q37134456 | Early detection of C-reactive protein and von Willebrand factor levels in Malaysian patients with acute coronary syndrome |
| Q35579968 | Early experience with a helical coronary thrombectomy device in patients with acute coronary thrombosis |
| Q46624759 | Effect of coffee drinking on platelets: inhibition of aggregation and phenols incorporation. |
| Q35642801 | Effect of genetic variations in platelet glycoproteins Ibalpha and VI on the risk for coronary heart disease events in postmenopausal women taking hormone therapy |
| Q47153008 | Effect of post-cessation hyperglycemia on cardiovascular disease and mortality among middle-aged men: an eight-year longitudinal study. |
| Q48103910 | Effect of sitagliptin on tissue characteristics of the carotid wall in patients with type 2 diabetes: a post hoc sub-analysis of the sitagliptin preventive study of intima-media thickness evaluation (SPIKE). |
| Q57822469 | Effect of smoking cessation on the risk of dementia: a longitudinal study |
| Q44507316 | Effect of the factor VII R353Q missense mutation on plasma apolipoprotein B levels: impact of visceral obesity |
| Q36908409 | Effects of altered plasminogen activator inhibitor-1 expression on cardiovascular disease |
| Q34028553 | Effects of antihypertensive therapy on hypertensive vascular disease |
| Q34107251 | Effects of diet and of dietary components on endothelial leukocyte adhesion molecules |
| Q43432297 | Effects of inflammatory cytokine gene polymorphisms on warfarin maintenance doses in Korean patients with mechanical cardiac valves |
| Q34348622 | Effects of kiwi fruit consumption on platelet aggregation and plasma lipids in healthy human volunteers |
| Q41998423 | Effects of treatment with oral isosorbide dinitrate on platelet function in vivo; a double-blind placebo-controlled study in patients with stable angina pectoris |
| Q43244897 | Efficacy of different doses of aspirin in decreasing blood levels of inflammatory markers in patients with cardiovascular metabolic syndrome |
| Q37995534 | Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke |
| Q53763072 | Electrical injury in the femoral artery of rabbits as a model for arterial thrombosis: a pilot study. |
| Q35878703 | Electrochemical impedance spectroscopy to assess vascular oxidative stress |
| Q35534303 | Electrochemical impedance spectroscopy to characterize inflammatory atherosclerotic plaques |
| Q37390765 | Emergence of targeted molecular imaging in atherosclerotic cardiovascular disease |
| Q37115819 | Emerging families of biomarkers for coronary artery disease: inflammatory mediators |
| Q33663306 | Emerging treatment of acute coronary syndromes with platelet glycoprotein IIB/IIIA inhibitors |
| Q43923355 | Endogenous anti-inflammatory response after coronary injury in a porcine model |
| Q40861583 | Endothelial dysfunction: implications for therapy of cardiovascular diseases |
| Q34289891 | Endothelin receptor antagonists and cardiovascular diseases of aging |
| Q28213718 | Enoxaparin injection for the treatment of high-risk patients with non-ST elevation acute coronary syndrome |
| Q90096050 | Evaluation of coronary artery disease in patients with atrial fibrillation by cardiac computed tomography for catheter ablation: CADAF-CT trial |
| Q28217728 | Evaluation of platelet function in aspirin treated patients with CAD |
| Q48250188 | Evaluation of the Effect of Alogliptin on Tissue Characteristics of the Carotid Wall: Subanalysis of the SPEAD-A Trial |
| Q42827084 | Evidence for a protein S receptor(s) on human vascular smooth muscle cells. Analysis of the binding characteristics and mitogenic properties of protein S on human vascular smooth muscle cells |
| Q38119278 | Evolution of intravascular assessment of coronary anatomy and physiology: from ultrasound imaging to optical and flow assessment |
| Q36725362 | Exposure to concentrated ambient particles does not affect vascular function in patients with coronary heart disease |
| Q34982919 | Exposure to smoking cues: cardiovascular and autonomic effects |
| Q33631516 | Expression of cell cycle regulators during smooth muscle cell proliferation after balloon catheter injury of rat artery |
| Q74016513 | Feasibility of intravascular ultrasound studies: predictors of imaging success before coronary interventions |
| Q42850358 | Few whiplash patients are malingerers |
| Q37379082 | Fibrinogen deficiency is compatible with the development of atherosclerosis in mice |
| Q51287668 | Flow recirculation zone length and shear rate are differentially affected by stenosis severity in human coronary arteries. |
| Q30409536 | Flow-dependent cellular mechanotransduction in atherosclerosis |
| Q40886414 | Free radical involvement in aging. Pathophysiology and therapeutic implications |
| Q40562735 | Functional characterization of tissue factor in von Willebrand factor-dependent thrombus formation under whole blood flow conditions. |
| Q37039019 | Functional expression of IgA receptor FcalphaRI on human platelets |
| Q34529610 | Functional property of von Willebrand factor under flowing blood |
| Q33735581 | Future directions in thrombolysis. |
| Q47581766 | GSTT1 null genotype contributes to coronary heart disease risk: a meta-analysis |
| Q37502883 | Garlic: nature's protection against physiological threats |
| Q43206016 | Gender differences in platelet aggregation in healthy individuals |
| Q21261432 | Genome-wide association and linkage analyses of hemostatic factors and hematological phenotypes in the Framingham Heart Study |
| Q24197696 | Glycaemic control for patients with acute coronary syndrome |
| Q26471811 | Glycaemic control for patients with acute coronary syndrome |
| Q33742233 | Glycoprotein IIb/IIIa receptor antagonists: clinical pharmacology in cardiovascular diseases of aging |
| Q34126038 | Glycoprotein IIb/IIIa receptor inhibitors in acute coronary syndromes: conquests and new challenges |
| Q44503897 | Glycoprotein Ib-mediated platelet activation. A signalling pathway triggered by thrombin. |
| Q36284581 | Grief counseling. |
| Q50648442 | Heart and vessel pathology underlying brain infarction in 142 stroke patients. |
| Q33821315 | Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus: chronic infections and coronary heart disease |
| Q51652334 | Hemodynamics of ulcerated plaques: before and after. |
| Q42554965 | Hemostatic risk factors in patients with coronary artery disease and type 2 diabetes - a two year follow-up of 243 patients |
| Q77659268 | Hepatocyte growth factor(HGF): a new biochemical marker for acute myocardial infarction |
| Q30736361 | High resolution in vivo intra-arterial imaging with optical coherence tomography |
| Q41334851 | High wall shear stress proximal to myocardial bridging and atherosclerosis: intracoronary ultrasound and pressure measurements |
| Q52544674 | High-Resolution magnetic resonance imaging of normal and atherosclerotic human coronary arteries ex vivo: discrimination of plaque tissue components. |
| Q34576092 | Higher fibrinogen level is independently linked with the presence and severity of new-onset coronary atherosclerosis among Han Chinese population |
| Q40466073 | Hirudin and Excess Bleeding Implications For Future Use |
| Q35043956 | Histamine blood concentration in ischemic heart disease patients |
| Q37596834 | Histopathologic characteristics of atherosclerotic coronary disease and implications of the findings for the invasive and noninvasive detection of vulnerable plaques |
| Q38306676 | Historical perspective on ADP-induced platelet activation |
| Q34211191 | Hostility and platelet reactivity in individuals without a history of cardiovascular disease events |
| Q36287932 | Hypercalcemia in cancer patients. Who, when and how to treat? |
| Q36601907 | Hypercholesterolemia and in-vivo coronary plaque composition in patients with coronary artery disease: a virtual histology - intravascular ultrasound study. |
| Q41250377 | Hyperinsulinaemia, insulin resistance, microalbuminuria and the risk of coronary heart disease |
| Q35930202 | Hyperintense plaque identified by magnetic resonance imaging relates to intracoronary thrombus as detected by optical coherence tomography in patients with angina pectoris |
| Q36816891 | Identification of patients at high risk for adverse coronary events while awaiting routine coronary angioplasty |
| Q35696276 | Identification of vulnerable atherosclerotic plaques |
| Q36410607 | Imaging of atherosclerosis using magnetic resonance: state of the art and future directions |
| Q36892171 | Imaging techniques for the vulnerable coronary plaque. |
| Q34011185 | Imaging techniques to predict cardiovascular risk. |
| Q40715307 | Impact of initial platelet count on baseline angiographic finding and end-points in ST-elevation myocardial infarction referred for primary percutaneous coronary intervention |
| Q34971125 | Impaired aortic distensibility measured by computed tomography is associated with the severity of coronary artery disease |
| Q44243351 | Impaired coronary artery distensibility is an endothelium-dependent process and is associated with vulnerable plaque composition |
| Q34180071 | Impaired modulation of circadian rhythms in patients with diabetes mellitus: a risk factor for cardiac thrombotic events? |
| Q28353718 | In vivo magnetic resonance imaging of experimental thrombosis in a rabbit model |
| Q34022293 | In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent |
| Q46268489 | In vivo non-invasive serial monitoring of FDG-PET progression and regression in a rabbit model of atherosclerosis |
| Q36930825 | In vivo optical coherence tomography of experimental thrombosis in a rabbit carotid model |
| Q36833376 | Increased serum concentrations of interleukin-1 beta in patients with coronary artery disease |
| Q71736481 | Induction of thrombolysis and prevention of thrombus formation by local drug delivery with a double-occlusion balloon catheter |
| Q38289775 | Induction of tissue factor expression in human endothelial cells by CD40 ligand is mediated via activator protein 1, nuclear factor kappa B, and Egr-1. |
| Q34532851 | Inflammation in acute coronary syndromes. |
| Q35201247 | Inflammatory and thrombotic mechanisms in coronary atherosclerosis |
| Q35489120 | Inflammatory markers, rather than conventional risk factors, are different between carotid and MCA atherosclerosis |
| Q35880758 | Influence of convolution filtering on coronary plaque attenuation values: observations in an ex vivo model of multislice computed tomography coronary angiography |
| Q45306468 | Influence of intracoronary attenuation on coronary plaque measurements using multislice computed tomography: observations in an ex vivo model of coronary computed tomography angiography |
| Q46892256 | Inhibition of 5-hydroxytryptamine receptor prevents occlusive thrombus formation on neointima of the rabbit femoral artery |
| Q37284659 | Inhibition of anastomotic intimal hyperplasia by a synthetic nonsulphated heparin-mimicking compound |
| Q54153329 | Inhibition of glucose uptake by 5-hydroxyindoleacetic acid in the isolated rat soleus muscle. |
| Q41655316 | Inhibition of platelet activity with red wine and grape products. |
| Q44910299 | Inhibition of streptokinase-induced, antibody-mediated platelet aggregation with tirofiban after exposure to streptokinase or streptococcal infection |
| Q35544852 | Inhibition of thrombosis and intimal thickening by in situ photopolymerization of thin hydrogel barriers |
| Q43453844 | Inhibitory Effect of Propolis on Platelet Aggregation In Vitro. |
| Q24317407 | Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor |
| Q70862353 | Interaction of antiplatelet drugs in vitro: aspirin, iloprost, and the nitric oxide donors SIN-1 and sodium nitroprusside |
| Q37023176 | Interleukin-18 enhances IL-18R/Nox1 binding, and mediates TRAF3IP2-dependent smooth muscle cell migration. Inhibition by simvastatin |
| Q37598013 | Intermediate-Risk Chronic Stable Angina: Neutrophil-Lymphocyte Ratio and Fibrinogen Levels Improved Predicting Angiographically-Detected Coronary Artery Disease. |
| Q37231485 | Intramural platelet deposition in cerebral vasculopathy of systemic lupus erythematosus |
| Q84890804 | Intravascular ultrasound assessment of the association between spatial orientation of ruptured coronary plaques and remodeling morphology of culprit plaques in ST-elevation acute myocardial infarction |
| Q28194358 | Investigation of platelet glycoprotein IIIa polymorphism using flow cytometry in patients with rheumatoid arthritis |
| Q42265142 | Irreversible platelet activation requires protease-activated receptor 1-mediated signaling to phosphatidylinositol phosphates |
| Q37860532 | Is Chlamydia pneumoniae a risk factor for peripheral atherosclerosis? |
| Q36178911 | Issues with care in the elderly patient presenting with acute ischemia |
| Q80168874 | Issues with care in the elderly patient presenting with acute ischemia |
| Q44424756 | LB30057, an orally effective direct thrombin inhibitor, prevents arterial and venous thrombosis in Rats and Dogs |
| Q33801932 | Laboratory Measurement of Thrombin Activity--What Every Clinician Scientist Needs to Know |
| Q37409035 | Lack of correlation between noninvasive stress tests and invasive coronary vasomotor dysfunction in patients with nonobstructive coronary artery disease |
| Q38012079 | Latest evidence in personalized antiplatelet therapy in patients with acute coronary syndromes undergoing percutaneous coronary intervention |
| Q39321756 | Left atrial myxoma as a cause of acute myocardial infarction. |
| Q82620198 | Left atrial myxoma associated with acute myocardial infarction and multiple cerebral infarctions: Report of a case |
| Q57312547 | Left ventricular dysfunction due to stunning and hibernation in patients |
| Q33706601 | Left ventricular mural thrombus and dual coronary embolization associated with hyperthyroid cardiomyopathy and atrial fibrillation: a case report |
| Q37389964 | Leukocyte count is associated with increased platelet reactivity and diminished response to aspirin in healthy individuals with a family history of coronary artery disease |
| Q43122848 | Levels of sCD40 ligand in chronic and acute coronary syndromes and its relation to angiographic extent of coronary arterial narrowing. |
| Q41059676 | Lipid peroxidation: a review of causes, consequences, measurement and dietary influences |
| Q42873238 | Lipid profiles and coronary artery plaque by CT angiography: Promise for translation of biology to imaging |
| Q56836112 | Lipoprotein(a) and cholesterol levels act synergistically and apolipoprotein A-I is protective for the incidence of primary acute myocardial infarction in middle-aged males. An incident case-control study from Sweden |
| Q41720842 | Local Delivery of an Ultra-short-acting Nitric Oxide-releasing Compound, DMHD/NO, Is Highly Effective in Inhibiting Acute Platelet-Thrombus Formation on Injured Arterial Strips |
| Q34580898 | Localization of oxidized low-density lipoprotein and its relation to plaque morphology in human coronary artery |
| Q36376147 | Long-term antithrombotic protection by in vivo depletion of platelet glycoprotein VI in mice |
| Q34075194 | Lotrafiban: an oral platelet glycoprotein IIb/IIIa blocker |
| Q84948895 | Low bone mineral density is not associated with angiographically determined coronary atherosclerosis in men |
| Q34027303 | Low molecular weight heparin in acute coronary syndromes |
| Q34027403 | Low molecular weight heparins and coronary artery disease |
| Q33704601 | Low-molecular-weight heparin should replace unfractionated heparin in the management of acute coronary syndromes |
| Q72248257 | Lowering blood lipids to treat atherosclerosis: vascular tone, plaques, events, and mortality |
| Q37662861 | Macrophages of genetically characterized familial hypercholesterolaemia patients show up-regulation of LDL-receptor-related proteins |
| Q35215288 | Macrovascular disease aetiology and diabetic foot ulceration. |
| Q35739811 | Magnetic resonance imaging and computed tomography in assessment of atherosclerotic plaque |
| Q30305538 | Management of Acute Ischemic Coronary Syndromes: The Present and Future |
| Q34820259 | Management of patients with acute coronary syndromes: what is the clinical role of direct thrombin inhibitors? |
| Q36348923 | Managing patients undergoing non-cardiac surgery: need to shift emphasis from risk stratification to risk modification |
| Q35582637 | Markers of inflammation and multiple complex stenoses (pancoronary plaque vulnerability) in patients with non-ST segment elevation acute coronary syndromes |
| Q37276523 | Measurement of von Willebrand factor as the marker of endothelial dysfunction in vascular diseases |
| Q35610914 | Medical angioplasty - hope and expectations: an optimistic overview |
| Q38803630 | Medicinal Plants with Antiplatelet Activity. |
| Q45099760 | Metabolic alterations in HIV-associated lipodystrophy syndrome |
| Q52508251 | Metal Ion Release from Mechanically-Disrupted Human Arterial Wall. Implications for the Development of Atherosclerosis |
| Q41006286 | Microfabrication for Drug Delivery |
| Q41007969 | Microfluidic assay of circulating endothelial cells in coronary artery disease patients with angina pectoris |
| Q37366066 | Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio |
| Q33216801 | Mineral volume and morphology in carotid plaque specimens using high-resolution MRI and CT. |
| Q37336662 | Moderate-intensity statin therapy seems ineffective in primary cardiovascular prevention in patients with type 2 diabetes complicated by nephropathy. A multicenter prospective 8 years follow up study |
| Q47297666 | Modifications in postprandial triglyceride-rich lipoprotein composition and size after the intake of pomace olive oil. |
| Q45156504 | Modulation of human monocyte CD36 by type 2 diabetes mellitus and other atherosclerotic risk factors |
| Q47761313 | Molecular identification of the cross-reacting epitope on alphaM beta2 integrin I domain recognized by anti-alphaIIb beta3 monoclonal antibody 7E3 and its involvement in leukocyte adherence |
| Q38478306 | Molecular imaging of alpha v beta3 integrin expression in atherosclerotic plaques with a mimetic of RGD peptide grafted to Gd-DTPA. |
| Q40361537 | Molecular imaging of vulnerable atherosclerotic plaques |
| Q44004395 | Morning cortisol production in coronary heart disease patients |
| Q77620224 | Morphometric and immunohistochemical characterization of the intimal layer throughout the arterial system of elderly humans |
| Q60607048 | Myocardial Salvage after Reduced-Dose Thrombolysis Combined with Glycoprotein IIb/IIIa Blockade Versus Thrombolysis Alone in Patients with Acute Myocardial Infarction |
| Q83505148 | Myocardial infarction due to coronary thrombosis in a patient with Henoch-Schönlein purpura |
| Q35252659 | Myocardial infarction in major noncardiac surgery: Epidemiology, pathophysiology and prevention |
| Q36304191 | Myocardial-cell replacement: the science, the clinic and the future |
| Q48600269 | Natriuretic peptide system gene expression in human coronary arteries |
| Q41720782 | New Antithrombotic Drugs of Coronary Artery Disease |
| Q26765488 | New Approaches to the Role of Thrombin in Acute Coronary Syndromes: Quo Vadis Bivalirudin, a Direct Thrombin Inhibitor? |
| Q37138669 | New and emerging risk factors for CVD. |
| Q33838920 | Newer antithrombotic strategies in the initial management of non-ST-segment elevation acute coronary syndromes |
| Q35918384 | Niemann-Pick C heterozygosity confers resistance to lesional necrosis and macrophage apoptosis in murine atherosclerosis |
| Q35172896 | Non-invasive detection of vulnerable coronary plaque |
| Q33244720 | Non-invasive imaging of atherosclerotic plaque macrophage in a rabbit model with F-18 FDG PET: a histopathological correlation |
| Q44524789 | Non-lipid effects of statins: myth or fact? |
| Q41197335 | Nonatherosclerotic causes of myocardial ischemia |
| Q40830644 | Noninvasive localization of human atherosclerotic lesions with indium 111-labeled monoclonal Z2D3 antibody specific for proliferating smooth muscle cells |
| Q34086042 | Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms |
| Q40716742 | Old concepts and new developments in the study of platelet aggregation |
| Q40389357 | Omega-3 fatty acids. Current status in cardiovascular medicine |
| Q30501519 | Optical coherence tomography: an emerging technology for biomedical imaging and optical biopsy |
| Q47647287 | Optimizing the Treatment of Unstable Angina. |
| Q41960983 | Optimizing the imaging protocol for ex vivo coronary artery wall using high-resolution MRI: an experimental study on porcine and human |
| Q34315317 | Oral health status of patients with acute coronary syndrome--a case control study |
| Q28181764 | Orbofiban: an orally active GPIIb/IIIa platelet receptor antagonist |
| Q35784872 | Organosulfur compounds from alliaceae in the prevention of human pathologies. |
| Q40915072 | Ovarian sex steroids and atherosclerosis |
| Q36396260 | Overview of hemostatic factors involved in atherosclerotic cardiovascular disease |
| Q40726298 | P2 receptors in atherosclerosis and postangioplasty restenosis |
| Q81060318 | P2 receptors in atherosclerosis and postangioplasty restenosis |
| Q33987096 | PGE2 decreases reactivity of human platelets by activating EP2 and EP4 |
| Q36310749 | Parallel comparison of risk factors between progression of organic stenosis in the coronary arteries and onset of acute coronary syndrome by covariance structure analysis |
| Q38631932 | Patchwork Coating of Fragmented Ultra-Thin Films and Their Biomedical Applications in Burn Therapy and Antithrombotic Coating. |
| Q33740239 | Pathogenesis and pathology of coronary heart disease syndromes |
| Q64938119 | Pathology of Endovascular Stents. |
| Q38401393 | Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis |
| Q38107887 | Patients who require non-cardiac surgery in acute coronary syndrome |
| Q80387665 | Patients with metabolic syndrome exhibit higher platelet activity than those with conventional risk factors for vascular disease |
| Q35969133 | Pericoronary Adipose Tissue as Storage and Supply Site for Oxidized Low-Density Lipoprotein in Human Coronary Plaques |
| Q36602669 | Periodontal disease and systemic conditions: a bidirectional relationship. |
| Q40036082 | Periodontitis as a risk factor for cardiovascular disease: the role of anti-phosphorylcholine and anti-cardiolipin antibodies |
| Q28360267 | Pharmacodynamics and safety of lefradafiban, an oral platelet glycoprotein IIb/IIIa receptor antagonist, in patients with stable coronary artery disease undergoing elective angioplasty |
| Q28171051 | Pharmacogenomics and drug response in cardiovascular disorders |
| Q36989841 | Pharmacogenomics of platelet responsiveness to aspirin |
| Q36787291 | Pharmacological antithrombotic adjuncts to percutaneous coronary intervention |
| Q34768517 | Pharmacotherapeutic options for the management of myocardial infarction |
| Q58230391 | Physiopathology of Acute Coronary Syndromes |
| Q35583277 | Plaque stabilisation by systemic and local drug administration. |
| Q37078045 | Plasma from systemic lupus patients compromises cholesterol homeostasis: a potential mechanism linking autoimmunity to atherosclerotic cardiovascular disease |
| Q36586261 | Plasminogen deficiency accelerates vessel wall disease in mice predisposed to atherosclerosis |
| Q39341052 | Platelet Function Testing-Guided Antiplatelet Therapy |
| Q38547727 | Platelet GP IIb-IIIa Receptor Antagonists in Primary Angioplasty: Back to the Future |
| Q80587956 | Platelet GPIbalpha, GPIV and vWF polymorphisms and fatal pre-hospital MI among middle-aged men |
| Q33819835 | Platelet Glycoprotein IIb/IIIa Integrin Blockade in Coronary Artery Disease: Current State of the Art. |
| Q73681288 | Platelet Inhibition in Cardiovascular Disease Management: Aspirin and Beyond |
| Q33704606 | Platelet PlA2 polymorphism and thromboembolic events: from inherited risk to pharmacogenetics |
| Q28219676 | Platelet activation in bypass surgery for critical limb ischemia |
| Q35945536 | Platelet activation increases in patients undergoing vascular surgery |
| Q51892930 | Platelet deposition in non-parallel flow: influence of shear stress and changes in surface reactivity. |
| Q34180960 | Platelet glycoprotein IIb/IIIa inhibitors combined with fibrinolytic agents to treat acute myocardial infarction |
| Q31934867 | Platelet glycoprotein IIb/IIIa receptor antagonists and coronary artery disease |
| Q36019811 | Platelet glycoprotein IIb/IIIa receptor antagonists in non-ST segment elevation acute coronary syndromes: a review and guide to patient selection |
| Q33826201 | Platelet glycoprotein IIb/IIIa receptor antagonists: current concepts and future directions |
| Q24793321 | Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease |
| Q30483148 | Platelet glycoprotein Ibalpha forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF. |
| Q36002765 | Platelet hyperreactivity: predictive and intrinsic properties |
| Q36958267 | Platelet microparticle number is associated with the extent of myocardial damage in acute myocardial infarction |
| Q43844783 | Platelet-dependent thrombin generation in patients with unstable angina pectoris |
| Q28165430 | Platelets as Predictors of Vascular Risk: Is There a Practical Index of Platelet Activity? |
| Q34486685 | Platelets: still a therapeutical target for haemostatic disorders |
| Q34645182 | Population genetic and phylogenetic evidence for positive selection on regulatory mutations at the factor VII locus in humans |
| Q26824610 | Positron emission tomography imaging of atherosclerosis |
| Q71736027 | Predicting ischaemic events in the perioperative period: in search of the perfect tool |
| Q44354602 | Preinterventional peak monocyte count and in-stent intimal hyperplasia after coronary stent implantation in human coronary arteries. |
| Q24563251 | Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis |
| Q36940776 | Prevalence of normal coronary angiography in the acute phase of suspected ST-elevation myocardial infarction: experience from the PRAGUE studies. |
| Q41206546 | Prevention and regression of atherosclerosis: effects of HMG-CoA reductase inhibitors |
| Q34220548 | Prevention of a first myocardial infarction |
| Q40890532 | Primary prevention of coronary heart disease. What has WOSCOPS told us and what questions remain? West Of Scotland Coronary Prevention Study. |
| Q72254127 | Probucol inhibits not only the progression of atherosclerotic disease, but causes a different composition of atherosclerotic lesions in WHHL-rabbits |
| Q77387638 | Proceedings of the 4th Invitational Wintergreen Conference. Wintergreen, Virginia, USA. July 12-14, 1998. Abstracts |
| Q37193597 | Prodrugs in cardiovascular therapy. |
| Q45863945 | Prognostic impact of lipid contents on the target lesion in patients with drug eluting stent implantation. |
| Q40411188 | Progression and regression of coronary artery disease--linkage of clinical, pathologic, and angiographic findings |
| Q33895700 | Proliferative activity in peripheral and coronary atherosclerotic plaque among patients undergoing percutaneous revascularization |
| Q35584014 | Proportion of fibrin and platelets differs in thrombi on ruptured and eroded coronary atherosclerotic plaques in humans |
| Q53656345 | Prospective comparison of coronary artery remodeling between acute coronary syndrome and stable angina in single‐vessel disease: Correlation between C‐reactive protein and extent of arterial remodeling |
| Q38616508 | Protease receptor antagonism to target blood platelet therapies |
| Q40169597 | Protective effects of red wine polyphenolic compounds on the cardiovascular system |
| Q36787244 | Proteomics in atherothrombosis: a future perspective |
| Q35047569 | Prothrombotic profile in patients with vasospastic or non vasospastic angina and non significant coronary stenosis |
| Q37398444 | Provinol inhibits catecholamine secretion from the rat adrenal medulla |
| Q43669893 | Quantification of coronary artery plaque using 64-slice dual-source CT: comparison of semi-automatic and automatic computer-aided analysis based on intravascular ultrasonography as the gold standard |
| Q34774208 | Quantitative evaluation of carotid atherosclerotic plaques by magnetic resonance imaging |
| Q34871660 | R353Q polymorphism in the factor VII gene and cardiovascular risk in Heterozygous Familial Hypercholesterolemia: a case-control study. |
| Q34912643 | Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECT |
| Q41256430 | Radiolabeled tirofiban - a potential radiopharmaceutical for detection of deep venous thrombosis |
| Q37196226 | Radionuclide imaging: a molecular key to the atherosclerotic plaque |
| Q35742697 | Rapid noninvasive detection of experimental atherosclerotic lesions with novel 99mTc-labeled diadenosine tetraphosphates |
| Q37304123 | Recent advances in atherosclerosis-based proteomics: new biomarkers and a future perspective. |
| Q35803300 | Recent advances in the management of unstable angina and non-Q-wave myocardial infarction |
| Q90467410 | Recurrent acute coronary syndrome due to coronary artery spasm in different coronary arteries |
| Q24316540 | Reduction of atherosclerosis in mice by inhibition of CD40 signalling |
| Q28167780 | Reduction of daily life ischaemia by aspirin in patients with angina: underlying link between thromboxane A2 and macrophage colony stimulating factor |
| Q35772174 | Relation between proinflammatory to anti-inflammatory cytokine ratios and long-term prognosis in patients with non-ST elevation acute coronary syndrome |
| Q73364814 | Reperfusion Injury: Does It Exist and Does It Have Clinical Relevance? |
| Q38665263 | Reperfusion strategies in acute myocardial infarction and multivessel disease |
| Q37805623 | Review: role of cerebral vessels in ischaemic injury of the brain |
| Q62760842 | Rheologische Determinanten von Endorgansch�den |
| Q44220002 | Risk factors differ for carotid artery plaque with and without acoustic shadowing. Atherosclerosis Risk in Communities Study Investigators |
| Q42578006 | Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content |
| Q38009702 | Risk stratification and timing of revascularization: which patients benefit from early versus later revascularization? |
| Q34445660 | Risk stratification in non-ST segment elevation acute coronary syndromes with special focus on recent guidelines. |
| Q28365442 | Risk stratification in unstable angina and non-Q wave myocardial infarction using soluble cell adhesion molecules |
| Q35557406 | Role of "Ischemia modified albumin", a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes |
| Q37378477 | Role of c-fos and E2F in the induction of cyclin A transcription and vascular smooth muscle cell proliferation |
| Q36819617 | Role of dietary polyphenols in platelet aggregation. A review of the supplementation studies |
| Q56765807 | Role of intravascular ultrasound imaging in identifying vulnerable plaques |
| Q40664634 | Role of platelets and leukocytes in modulation of vascular tone |
| Q35833262 | Rous-Whipple Award Lecture. Atherosclerosis: a defense mechanism gone awry. |
| Q51349502 | Routinely available biomarkers improve prediction of long-term mortality in stable coronary artery disease: the Vienna and Ludwigshafen Coronary Artery Disease (VILCAD) risk score. |
| Q54325092 | S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-κB signaling. |
| Q44252400 | Selectin-P and interleukin-8 plasma levels in coronary heart disease patients |
| Q40730538 | Serum levels of IL-1, IL-6 and tumour necrosis factors in patients undergoing coronary artery bypass grafts or cholecystectomy |
| Q48589128 | Sex-related dimorphic response of HIF-1 alpha expression in myocardial ischemia |
| Q36204756 | Shaping bio-inspired nanotechnologies to target thrombosis for dual optical-magnetic resonance imaging |
| Q58390508 | Shear stress-induced pH increase in plasma is mediated by a decrease in PCO2: The increase in pH enhances shear stress-induced P-selectin expression in platelets |
| Q74050918 | Shear-induced platelet aggregation increases in patients with proximal and severe coronary artery stenosis |
| Q44761374 | Short-term effect of low-dose atorvastatin on haemorrheological parameters, platelet aggregation and endothelial function in patients with cerebrovascular disease and hyperlipidaemia |
| Q34989717 | Single nucleotide polymorphism network: a combinatorial paradigm for risk prediction |
| Q35376940 | Size of emptied plaque cavity following spontaneous rupture is related to coronary dimensions, not to the degree of lumen narrowing. A study with intravascular ultrasound in vivo |
| Q53537606 | Skeletal myoblasts transplanted in the ischemic myocardium enhance in situ oxygenation and recovery of contractile function. |
| Q37308636 | Small molecule inhibitors of integrin alpha2beta1. |
| Q38121847 | Soluble amyloid precursor protein 770 is a novel biomarker candidate for acute coronary syndrome |
| Q36418965 | Soluble amyloid precursor protein 770 is released from inflamed endothelial cells and activated platelets: a novel biomarker for acute coronary syndrome |
| Q35100297 | Statin treatment and progression of atherosclerotic plaque burden |
| Q36376883 | Steam-cooking rapidly destroys and reverses onion-induced antiplatelet activity |
| Q74592557 | Strategic targeting of atherosclerotic lesions |
| Q44068884 | Structure-activity relationships of heparin-mimicking compounds in induction of bFGF release from extracellular matrix and inhibition of smooth muscle cell proliferation and heparanase activity |
| Q83835651 | Study of V1a vasopressin receptor gene single nucleotide polymorphisms in platelet vasopressin responsiveness |
| Q40307089 | Synthesis and biological evaluation of some dibenzofuran-piperazine derivatives |
| Q42776167 | Synthesis of NanoQ, a copper-based contrast agent for high-resolution magnetic resonance imaging characterization of human thrombus |
| Q41669761 | Systemic Inflammatory Response Syndrome is an Independent Predictor of One-Year Mortality in Patients with Acute Myocardial Infarction |
| Q34832382 | Target heart rate to determine the normal value of coronary flow reserve during dobutamine stress echocardiography |
| Q33417854 | Targeting integrin and integrin signaling in treating thrombosis |
| Q26744359 | Targeting the Innate Immune Response to Improve Cardiac Graft Recovery after Heart Transplantation: Implications for the Donation after Cardiac Death |
| Q37711301 | Telomeres and Estrogens: The Unholy Nexus in Pathogenesis of Atherosclerosis |
| Q46182070 | Temporal gene expression analysis of human coronary artery endothelial cells treated with Simvastatin. |
| Q33264678 | Testing various fruits for anti-thrombotic effect: i. Mulberries |
| Q33572281 | The Optimal Route of Administration of the Glycoprotein IIb/IIIa Receptor Antagonist Abciximab During Percutaneous Coronary Intervention; Intravenous Versus Intracoronary |
| Q37331185 | The P2Y2 receptor mediates uptake of matrix-retained and aggregated low density lipoprotein in primary vascular smooth muscle cells |
| Q35584004 | The Role of Glycoprotein IIb/IIIa-Receptor Antagonists in Diabetics |
| Q46011354 | The VYtorin on Carotid intima-media thickness and overall arterial rigidity (VYCTOR) study. |
| Q52854991 | The association between hyperglycaemia and elevated troponin levels on mortality in acute coronary syndromes. |
| Q46535633 | The atherosclerotic plaque: a healthy challenge to the limits of nuclear imaging |
| Q41192732 | The distal pathway of lipoprotein-induced cholesterol esterification, but not sphingomyelinase-induced cholesterol esterification, is energy-dependent. |
| Q36881789 | The dynamic vasa vasorum |
| Q33252652 | The eccentric lumenology |
| Q24298078 | The effect of a single nucleotide polymorphism on human alpha 2-antiplasmin activity |
| Q44092959 | The effects of combination therapy with niceritrol and pravastatin on hyperlipidaemia |
| Q43081743 | The effects of cyclooxygenase and nitric oxide synthase inhibition on cardiodynamic parameters and coronary flow in isolated rat hearts |
| Q40442876 | The glycoprotein IIIa gene polymorphism and the risk of myocardial infarction |
| Q44777255 | The influence of red wine or white wine intake on platelet function and viscoelastic property of blood in volunteers |
| Q37947959 | The management of thrombotic lesions in the cardiac catheterization laboratory |
| Q55475006 | The natural course of nonculprit coronary artery lesions; analysis by serial quantitative coronary angiography. |
| Q51071291 | The nature of the depressive symptomatology preceding myocardial infarction. |
| Q34761170 | The potential role of AT(1)-receptor blockade in the prevention and reversal of atherosclerosis |
| Q52601414 | The relationship between CD40 gene polymorphism and unstable coronary atherosclerotic plaques. |
| Q33835675 | The relationship of hydroxyeicosatetraenoic acids and F2-isoprostanes to plaque instability in human carotid atherosclerosis |
| Q48005312 | The response of smooth muscle cells to alpha-thrombin depends on its arterial origin: comparison among different species |
| Q77940039 | The role of cardiac troponin-I (cTnI) in risk stratification of patients with unstable coronary artery disease |
| Q34685608 | The role of thrombin inhibition during percutaneous coronary intervention |
| Q28200757 | The safety and efficacy of aspirin and clopidogrel as a combination treatment in patients with coronary heart disease |
| Q55026371 | The significance of circulating endothelin-1 as a predictor of coronary artery disease status and clinical outcomes following coronary artery catheterization. |
| Q58136303 | The use of echocardiography for the non-invasive evaluation of coronary artery disease |
| Q34327214 | The use of statins in acute coronary syndromes: the mechanisms behind the outcomes |
| Q40779843 | The vascular endothelium. A new horizon |
| Q36484662 | Thiazolidinediones: effects on insulin resistance and the cardiovascular system |
| Q46819564 | Three-dimensional recovery time dispersion map by 64-channel magnetocardiography may demonstrate the location of a myocardial injury and heterogeneity of repolarization |
| Q73681259 | Thrombin Generation in Patients with Acute Myocardial Infarction Treated with Front-Loaded rt-PA and Recombinant Hirudin (HBW 023) |
| Q36233524 | Thrombin adhesive properties: induction by plasmin and heparan sulfate |
| Q35607594 | Thrombin receptor expression in normal and atherosclerotic human arteries |
| Q40938710 | Thrombosis and the pharmacology of antithrombotic agents |
| Q38243253 | Thrombosis formation on atherosclerotic lesions and plaque rupture |
| Q42340251 | Thrombus aspirated from patients with ST-elevation myocardial infarction: Clinical and angiographic outcomes |
| Q41082129 | Tissue factor is induced by monocyte chemoattractant protein-1 in human aortic smooth muscle and THP-1 cells. |
| Q33900126 | Tissue factor is rapidly induced in arterial smooth muscle after balloon injury |
| Q26798568 | Tocopherols in the Prevention and Treatment of Atherosclerosis and Related Cardiovascular Disease |
| Q36422381 | Toll-like receptor-4 is upregulated in plaque debris of patients with acute coronary syndrome more than Toll-like receptor-2. |
| Q34107489 | Treating ambulatory ischemia in coronary disease by manipulating the cell biology of atherosclerosis |
| Q33579199 | Treating myocardial infarction in the post-GUSTO era. A European perspective |
| Q33754183 | Trials of glycoprotein IIb-IIIa inhibitors in non-ST-segment elevation acute coronary syndromes: applicability to the practice of medicine in the United States |
| Q30446520 | Ultrasonic tissue characterization of carotid plaque improves the prediction of cardiovascular events in diabetic patients: a pilot study |
| Q35080311 | Ultrasound angioplasty: an update review |
| Q49967981 | Unstable angina pectoris. |
| Q34811590 | Update on the NCEP ATP-III emerging cardiometabolic risk factors |
| Q37846370 | Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention. |
| Q33663297 | Use of glycoprotein IIb/IIIa inhibition plus fibrinolysis in acute myocardial infarction |
| Q28212381 | Use of unfractionated heparin and a low-molecular-weight heparin following thrombolytic therapy for acute ST-segment elevation myocardial infarction |
| Q51371134 | Utility of high fat and low carbohydrate diet in suppressing myocardial FDG uptake. |
| Q73295838 | Vascular Applications of Human Gene Therapy |
| Q36733219 | Vascular endothelial growth factor and monocyte chemoattractant protein-1 levels unaltered in symptomatic atherosclerotic carotid plaque patients from north India |
| Q64058724 | Vasoconstrictor component of atherothrombotic culprit lesions in ST-segment elevation myocardial infarction |
| Q41155350 | Verapamil: a review of its pharmacological properties and therapeutic use in coronary artery disease |
| Q37336541 | Volume and composition of emboli in neuroprotected stenting of the carotid artery |
| Q46298247 | WITHDRAWN: Effect of cilostazol in alleviating cardiovascular complications through regulation of type 1 plasminogen activator inhibitor and transforming growth factor-β1 overexpression in experimental rats |
| Q74084731 | [Conservative therapeutic approaches in terminal coronary heart disease. Chronic intermittent urokinase therapy] |
| Q73298197 | [Endothelial dysfunction in patients with acute coronary syndrome] |
| Q73540801 | [Genetic risk factors for myocardial infarct] |
| Q77782856 | [Successful emergency coronary artery bypass grafting after use of a percutaneous cardiopulmonary support system in a patient with cardiopulmonary arrest secondary to acute myocardial infarction] |
| Q74564766 | [The role of endothelial function for ischemic manifestations of coronary atherosclerosis] |
| Q33654586 | d-alpha-tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties |
| Q73101411 | von Willebrand factor |
Search more.